Robert Neely

Robert Neely has a diverse work experience spanning multiple roles in the biotechnology and pharmaceutical industries. Robert is currently working as the Scientific Director-Translational Sciences at Immunologix Laboratories since October 2022. Prior to this, they held various positions at Bristol-Myers Squibb, starting in 2010. Robert'sroles at Bristol-Myers Squibb included Associate Director, Pharmacodiagnostics, where they provided subject matter expertise in the development and execution of companion/complementary biomarker diagnostic programs. Robert also served as a Senior Research Investigator, leading a team in bioanalytical ligand binding assays and providing strategic input for biomarker support. Before that, they worked as a Research Investigator II and Research Investigator, contributing to the development and implementation of bioanalytical ligand binding assays for various biomarker programs.

Prior to joining Bristol-Myers Squibb, Robert Neely worked as a Graduate student at Thomas Jefferson University from 2003 to 2010. Robert also had a role as a Non-Traditional graduate studies and research technician at the University of Pennsylvania from 1999 to 2002.

Robert Neely obtained a Bachelor of Science degree in Biology from Rider University, where they studied from 1995 to 1999. Following this, they pursued non-traditional graduate studies at the University of Pennsylvania from 2000 to 2002. Finally, they completed their education by earning a PhD in Immunology and Microbial Pathogenesis from Jefferson Health, where they studied from 2003 to 2010.